King’s College London highlighted the distinct and shared molecular pathways linking cannabis use disorder and psychosis, offering the potential for identifying those at risk, as well as targeted interventions for cannabis-related psychosis. Its analysis of the data identified over 500 genetic loci associated with psychosis, which includes 122 novel links.


